Table 6. Concentrations with standard deviations of target antimicrobial residues in raw and treated water of NW-E DWPF.
Date | Sampling sites | Ampicillin (μg/L) | Ciprofloxacin (μg/L) | Sulfamethoxazole (μg/L) | Trimethoprim (μg/L) | Fluconazole (μg/L) |
---|---|---|---|---|---|---|
Oct-20 | Raw inlet 1 | 5.95±0.84 | 3.43±0.41 | 3.46±0.52 | <LOQ | <LOQ |
Raw inlet 2 | 12.97±0.12 | 4.91±0.73 | 3.78±0.13 | <LOQ | <LOQ | |
Treated water | 8.10±0.85 | 3.42±0.28 | 2.85±0.49 | <LOQ | <LOQ | |
Nov-20 | Raw inlet 1 | 8.90±1.13 | <LOQ | 1.53±0.37 | 0.18±0.00 | <LOQ |
Raw inlet 2 | 11.55±2.09 | <LOQ | <LOQ | <LOQ | <LOQ | |
Treated water | 11.53±4.15 | <LOQ | <LOQ | 0.19±0 | <LOQ | |
Dec-20 | Raw inlet 1 | 16.85±3.45 | 0.95±0.18 | 2.03±0.37 | 0.82±0.04 | <LOQ |
Raw inlet 2 | 24.58±4.59 | 0.74±0.23 | 2.00±0.13 | 0.24±0.01 | <LOQ | |
Treated water | 12.56±0.37 | 0.83±0.18 | <LOQ | 0.20±0.01 | <LOQ | |
Feb-21 | Raw inlet 1 | 25.81±1.81 | 2.25±0.05 | <LOQ | <LOQ | <LOQ |
Raw inlet 2 | 11.79±2.37 | 2.83±0.74 | <LOQ | 0.17±0.03 | <LOQ | |
Treated water | 10.02±0.04 | 0.60±0.04 | <LOQ | <LOQ | <LOQ | |
Jul-21 | Raw inlet 1 | 4.20±0.17 | 1.32±0.20 | <LOQ | 0.40±0.03 | <LOQ |
Raw inlet 2 | 6.10±2.34 | 0.87±0.01 | <LOQ | 0.22±0.02 | <LOQ | |
Treated water | 2.83±0.38 | 0.55±0.07 | <LOQ | 0.25±0.01 | <LOQ | |
Aug-21 | Raw inlet 1 | 27.77±1.29 | 1.37±0.30 | <LOQ | 0.40±0.01 | <LOQ |
Raw inlet 2 | 11.92±0.06 | <LOQ | <LOQ | <LOQ | <LOQ | |
Treated water | 3.27±0.10 | 1.00±0.06 | <LOQ | 0.39±0.05 | <LOQ | |
Feb-22 | Raw inlet 1 | 18.89±3.81 | 46.52±1.47 | 2.64±0.26 | 0.35±0.02 | 9.49±0.78 |
Raw inlet 2 | 20.08±3.68 | 0.44±0.00 | 1.65±0.12 | 0.33±0.01 | 19.03±5.78 | |
Treated water | 14.18±3.81 | 0.75±0.09 | 2.64±0.12 | 0.32±0.04 | 8.34±1.50 |
LOQ–limit of quantification